Indofarma Tbk. vs Multistrada Arah Sarana Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Multistrada Arah Sarana Tbk. trades at Rp6,200 (market cap 56.93T). The key difference: Multistrada Arah Sarana Tbk. is far larger — about 145.8× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | MASA | |
|---|---|---|
Market Cap | 390.51B | 56.93T |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →Multistrada Arah Sarana, PT (the company) was established under its original name of PT Oroban Perkasa on Jun 20th 1988. The company starts commercial operation in 1995. The articles of association have been amended several times, most recently on January 31, 2005, concerning public offering.
Read more on MASA →